Sezary syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Sezary syndrome}} {{CMG}}; {{AE}} ==Overview== ==Historical Perspective== ===Discovery=== * There is limited information about the historical perspective of [di...") |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Sezary syndrome}} | {{Sezary syndrome}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{S.G.}} | ||
==Overview== | ==Overview== | ||
==Historical Perspective== | ==Historical Perspective== | ||
* Sezary syndrome (SS) was first described by Albert Sézary in 1938.<ref name="pmid16871044">{{cite journal |vauthors=Steffen C |title=The man behind the eponym dermatology in historical perspective: Albert Sézary and the Sézary syndrome |journal=Am J Dermatopathol |volume=28 |issue=4 |pages=357–67 |date=August 2006 |pmid=16871044 |doi= |url=}}</ref> | |||
=== | * The association between cell count of [[Lymphocyte|lymphocytes]] in the peripheral [[blood]] with [[Groove for sigmoid sinus|grooved]], lobulated (that is, “cerebriform”) [[nuclei]] and Sezary syndrome was made in the early to mid-20th century.<ref name="pmid266071834">{{cite journal |vauthors=Wilcox RA |title=Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management |journal=Am. J. Hematol. |volume=91 |issue=1 |pages=151–65 |date=January 2016 |pmid=26607183 |pmc=4715621 |doi=10.1002/ajh.24233 |url=}}</r=ef> | ||
* | |||
=== | |||
=== | |||
Revision as of 15:54, 13 February 2019
|
Sezary syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sezary syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Sezary syndrome historical perspective |
|
Risk calculators and risk factors for Sezary syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Historical Perspective
- Sezary syndrome (SS) was first described by Albert Sézary in 1938.[1]
- The association between cell count of lymphocytes in the peripheral blood with grooved, lobulated (that is, “cerebriform”) nuclei and Sezary syndrome was made in the early to mid-20th century.<ref name="pmid266071834">Wilcox RA (January 2016). "Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management". Am. J. Hematol. 91 (1): 151–65. doi:10.1002/ajh.24233. PMC 4715621. PMID 26607183.</r=ef>